KBP Biosciences Lands $76M, an Ex-GlaxoSmithKline Exec as Its New CEO and a HQ Move to Philly Post author:Sam Post published:January 4, 2018 Post category:BioPharma The financing was co-led by Advantech Capital and SDIC Venture Capital. Source: BioSpace You Might Also Like Tax Reform: A War on Life Sciences Innovation December 11, 2017 Following Recent Death, InVivo Therapeutics Temporarily Halts Enrollment in INSPIRE Study July 30, 2017 Meet the Little-Known Chinese CAR-T Biotech Up More Than 500% Since June 2017 February 13, 2018
Following Recent Death, InVivo Therapeutics Temporarily Halts Enrollment in INSPIRE Study July 30, 2017
